News

European Medical Journal1h
CT Metrics Predict ALS Survival as Well as Traditional Spirometry
Understand how CT metrics match FVC in predicting ALS survival, offering a spirometry alternative for patients with bulbar ...
FDA grants clearance to BrainStorm’s Phase IIIb trial of ALS treatment
The US Food and Drug Administration (FDA) has granted clearance to BrainStorm Cell Therapeutics to commence a Phase IIIb ...
Stocktwits on MSN11h
Retail Bulls Cheer FDA Clearance For BrainStorm’s ALS Therapy, But Shares Dip After Hours
BrainStorm Cell Therapeutics saw rising retail chatter Monday when it obtained FDA clearance for Phase 3b clinical trials of ...
WFRV Local 513h
Local family shares experience with familial ALS and efforts to fund research to find a cure
In a story of resilience and hope, the Weber family stands as a reminder of the impact of familial bonds in the face of ...
Micro Cap Bid Up Aggressively On FDA Clearance Announcement
A New York-based biotech company is already turning heads during Monday’s premarket hours after it was announced that the ...
ALS News Today22h
Neuronata-R improved function, survival in slow-progressing ALS
Patients given Neuronata-R who progressed more slowly saw significant gains in CAFS, slower declines in ALSFRS-R scores, and ...
BrainStorm Cell Therapeutics Inc.: BrainStorm Receives FDA Clearance to Initiate Phase 3b Trial of NurOwn for ALS
Investor call and webcast scheduled for today at 8:30 a.m. ET NEW YORK, May 19, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading ...